Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Stock Advisor

Your next 5 stock picks, already researched. Just click.

Recently Viewed

Clear All

Accretion Pharmaceuticals IPO

Listed Listed stocks

Accretion Pharmaceuticals IPO Details

  • Bidding Date

    14-May-2025 to
    16-May-2025

  • Issue Size

    ₹29.75 Cr

  • Price Band

    ₹96 to ₹101

  • Allotment date

    19-May-2025

  • Listing date

    21-May-2025

  • Lot size

    1200

  • No. of shares

    29,46,000

  • Fresh issue/OFS

    ₹29.75 Cr /--

About Accretion Pharmaceuticals Company

Accretion Pharmaceuticals Limited, established in 2012, operates as a pharmaceutical Contract Development and Manufacturing Organization (CDMO), primarily engaged in the manufacturing and marketing of a wide range of dosage forms including tablets, capsules, oral liquids, external preparations (such as ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders), and oral powders like sachets and dry syrups. The company conducts its business through multiple models—direct sales in the domestic and export markets, as well as contract manufacturing and loan license arrangements for third-party marketers. Geographically, Gujarat remains the company’s most significant market, contributing over 85% of domestic revenue consistently over the years. Product-wise, the majority of the revenue comes from tablets, oral liquids, and capsules, with tablets alone contributing approximately 40% of the revenue in recent financial years.

Subscription Status

  • Category

    Status

  • QIBs

    --

  • NIIs

    --

  • Retail

    --

  • Others

    --

  • Total

    3.9x

Accretion Pharmaceuticals Financials

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Aureate Tradde 70 29-May-2026 to 02-Jun-2026
Merritronix 141 - 149 01-Jun-2026 to 03-Jun-2026
Rajnandini Fashion India 59 - 63 26-May-2026 to 29-May-2026
SMR Jewels 128 - 135 26-May-2026 to 29-May-2026
IPO MonitorIPO Monitor

FAQs for Accretion Pharmaceuticals IPO.

The issue size of Accretion Pharmaceuticals is ₹29.75 Cr.

Accretion Pharmaceuticals falls into Pharmaceuticals industry.

The Accretion Pharmaceuticals IPO will be listed on BSE.

The open and close dates for the Accretion Pharmaceuticals are 14-May-2025 & 16-May-2025.

The price band for the Accretion Pharmaceuticals ipo is ₹96 to ₹101

The listing date of Accretion Pharmaceuticals IPO is 21-May-2025.

The purpose of this IPO is to raise fresh capital.

Accretion Pharmaceuticals total subscription ratio is 3.9X.

Key financial of the Accretion Pharmaceuticals are:


Accretion Pharmaceuticals FY-25 FY-24
Revenue (₹ Cr) 57.38 13.35
EBIT (₹ Cr) 11.11 2.34
Proft after Tax (₹ Cr) 6.79 1.49
Debt (₹ Cr) 14.1 13.48
Net Worth (₹ Cr) 15.29 5.49
RoE (%) 44.44 27.18

Home > IPO Monitor > Accretion Pharmaceuticals